Drawing for Serial No. 75526700

USPTO serial 75526700

Serial No. 75526700

Reviewed by CopyMark Law Group

Reg. 2344618Status 800Registered
Filing date
Status date
Registration date
Apr 25, 2000
Examiner
AIKENS, RONALD E
Law office
TMEG LAW OFFICE 103

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with Serial No. 75526700?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arlene D. Hanks

Arlene D. Hanks Moore & Van Allen PLLC100 North Tryon StreetSuite 4700Charlotte, NC 28202-4003

Goods and services

ClassDescriptionStatusFirst use
009[ Computer software for managing clinical trial data and information in the field of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices]SECTION 8 - CANCELLED—
035COMPUTERIZED DATABASE MANAGEMENT AND DATA PROCESSING SERVICES IN THE FIELDS OF PHARMACEUTICAL, [VETERINARY,] PHARMACOGENOMIC, BIOTECHNICAL AND MEDICAL PRODUCTS AND DEVICES; [ MANUFACTURERS' SALES REPRESENTATIVES IN THE FIELDS OF PHARMACEUTICAL, VETERINARY, PHARMACOGENOMIC, BIOTECHNICAL AND MEDICAL PRODUCTS AND DEVICES;] BUSINESS MARKETING AND CONSULTING SERVICES IN THE FIELDS OF PHARMACEUTICAL, [VETERINARY, ] PHARMACOGENOMIC, BIOTECHNICAL AND MEDICAL PRODUCTS AND DEVICESACTIVEFeb 1, 1982
042CLINICAL RESEARCH AND TESTING IN THE FIELDS OF PHARMACEUTICAL, [VETERINARY,] PHARMACOGENOMIC, BIOTECHNICAL AND MEDICAL PRODUCTS AND DEVICES; CONSULTATION SERVICES IN THE FIELDS OF PHARMACEUTICAL, [VETERINARY,] PHARMACOGENOMIC, BIOTECHNICAL AND MEDICAL PRODUCTS AND DEVICES; HEALTHCARE POLICY RESEARCH AND DEVELOPMENT SERVICES; LABORATORY TESTING SERVICES IN THE FIELDS OF PHARMACEUTICAL, [VETERINARY, ]PHARMACOGENOMIC, BIOTECHNICAL AND MEDICAL PRODUCTS AND DEVICESACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 29, 2019NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
May 29, 2019RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
May 29, 20199G8PREGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8—
May 29, 20198PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
May 29, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 25, 2019E89RTEAS SECTION 8 & 9 RECEIVED—
Apr 25, 2019REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 18, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 17, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 1, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 19, 2016ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 12, 2016ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 27, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 20, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 17, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 5, 2010RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Apr 5, 201089AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Mar 31, 2010E89RTEAS SECTION 8 & 9 RECEIVED—
Jul 19, 2006C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 13, 2006PLGLASSIGNED TO PARALEGAL—
Apr 18, 2006815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Apr 18, 2006E815TEAS SECTION 8 & 15 RECEIVED—
Apr 5, 2006ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 5, 2006CFITCASE FILE IN TICRS—
Apr 25, 2000R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 1, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 30, 1999NPUBNOTICE OF PUBLICATION—
Nov 19, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 1, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 16, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 19, 1999DOCKASSIGNED TO EXAMINER—
Feb 19, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance